M. Gates et al., Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro, NEUROPHARM, 40(8), 2001, pp. 984-991
The present study describes the pharmacological activity of two novel posit
ive allosteric modulators at AMPA receptors in acutely isolated rat cerebel
lar Purkinje neurons and cultured rat hippocampal neurons. Currents elicite
d by application of glutamate (100 muM) to isolated cerebellar Purkinje neu
rons were potentiated by LY392098, LY404187, cyclothiazide, CX516 and anira
cetam. The rank order of potency was LY404187 > LY392098 > cyclothiazide >
CX516 > aniracetam. LY392098 displayed a higher maximal efficacy than the o
ther compounds examined. AMPA-activated inward currents in cultured rat hip
pocampal neurons were potentiated by LY392098, LY404187 and cyclothiazide i
n a reversible and concentration-dependent manner although considerable het
erogeneity in the magnitude of response from cell to cell was observed. LY3
92098 was ineffective in potentiating AMPA receptor responses when dialyzed
via the intracellular solution. The selectivity profiles of the two novel
AMPA receptor potentiators were examined. LY392098 or LY404187 had minimal
activity on NMDA receptor responses, on voltage-gated calcium channel curre
nts in cultured hippocampal neurons and on GluR5 kainate receptor currents
in acutely isolated rat dorsal root ganglion neurons. (C) 2001 Elsevier Sci
ence Ltd. All rights reserved.